Verdict: Justified
Key finding: Teradyne beat Q3 and guided Q4 EPS above consensus, but Q4 revenue guidance ($1.25-1.35B) is flat with Q3. Revenue has sat at $1.28-1.33B for four straight quarters, and year-over-year growth drops from +104% (Q2) to +70% (Q3) to about +20% at the Q4 midpoint. Gross margin slipped for the third quarter in a row. Chip peers are up today, so the drop is Teradyne-specific.
Since last dive
- 10/22 dive: verdict mixed, $321.49. That drop was sector sympathy with Lam Research (shortages, lower China), with no Teradyne news, and the call was left open until this report.
- Price: $321.49 to $296.66 now (-7.7%). The stock held $304-309 for three sessions, rose +4.75% into the print on 10/27 (close $323.68), then gapped down.
- Earnings (new, decisive): Q3 came in above the high end of guidance. The release does not mention supply shortages outside the standard risk factors, so Lam's shortage problem did not show up in Teradyne's numbers. The negative is different: the growth plateau above.
- Sector: improved since 10/22. SMH is $562.78 today (+0.9%) vs the $532-536 test on 10/22, so the group is no longer the reason.
- The verdict changes from mixed to justified. The open question from 10/22 (would the report confirm the sell-off?) is answered: the business is intact, but growth has flattened, and a ~7% repricing fits that.
Scorecard
| Ticker | Rev last Q ($M) | Rev YoY last Q | Rev YoY prior Q | Gross margin (last Q, trend) | Op margin | EPS last Q vs yr ago | P/S | Mkt cap | 1-mo price % |
|---|---|---|---|---|---|---|---|---|---|
| TER (Sep Q) | 1,306 | +69.8% | +103.9% | 59.1% (down from 59.8%, 60.9%) | 30.8% | 2.17 vs 0.75 | 9.3 | $46.4B | -18.8% |
| FORM (Jun Q) | 258 | +31.9% | +32.0% | 50.7% (up from 47.9%) | 22.4% | 0.70 vs 0.12 | 9.5 | $8.6B | -17.6% |
| COHU (Jun Q) | 149 | +38.4% | +29.3% | 45.4% (up from 40.5%) | 0.2% | -0.00 vs -0.36 | 4.7 | $2.5B | -23.9% |
| AEHR (May Q) | 20 | +40.2% | -43.7% | 40.6% (up from 32.7%) | -5.0% | 0.05 vs -0.10 | 41.7 | $2.1B | -38.7% |
TER = Q3 from the 10/27 release (GAAP); peers = latest reported quarter (Q3 not yet reported). 1-mo % = 9/25 to 10/27 close. TER P/S and market cap at today's $296.66.
TER is still the quality leader of the test group, with growth (+70%) about 2x the peers and the highest op margin (30.8%). The lead is shrinking: TER's growth and margins are decelerating, while FORM, COHU and AEHR show rising gross margins. On P/S, TER (9.3) now trades in line with FORM (9.5) instead of at a premium.
Move
- Prior close $323.68 (10/27, +4.75% on the day). Fell about 6.7% after hours on the report (Investing.com, Tickeron).
- Opened $302.01 (-6.69%), low $295.92 in the first minutes, $296.66 at 9:32 ET (-8.3%). That is 531K shares in 3 minutes vs a 50-day average of 2.66M a day.
- Price is now testing the 2026 floor: $301.86 (4/29 low), $296.82 (7/17 low), $301.00 (7/28 low). Today's low is the first trade under $296.82 since the June top. The stock is 39% below its all-time high of $487.91 (6/30) and below its 50-day ($369.87) and 200-day ($348.52) averages.
- This is the third straight earnings sell-off in 2026: Q1 (4/29) opened -17.3% and closed -19.4%. Q2 (7/29) gapped up +14.7% to $367.90 and closed at $319.41 (-0.4%), giving back the whole gap.
- Peers today (FMP, ~9:30 ET): FORM +2.4%, COHU +1.8%, AEHR +1.5%, LRCX +2.1%, KLAC +1.6%, SMH +0.9%.
Catalyst
Q3 2026 results, released 10/27 after the close (8-K exhibit 99.1):
- Revenue $1,306M, up 70% YoY (Q3'25 $769M) and down from $1,329M in Q2. Consensus was ~$1.26B, and the result was above the high end of the $1.20-1.30B guide.
- Semiconductor Test $1,072M, Product Test $138M, Robotics $96M. Robotics had its highest Q3 revenue ever and turned profitable. Memory and Integrated Systems Test set revenue records "driven by AI demand".
- GAAP gross margin 59.1%, GAAP op income $402.0M (30.8%), non-GAAP op margin 31.6%. GAAP EPS $2.17, non-GAAP $2.29 vs ~$2.08 consensus.
- Q4 guide: revenue $1,250-1,350M (midpoint $1,300M, flat with Q3; about +20% YoY vs Q4'25 $1,083M), GAAP EPS $1.88-2.18, non-GAAP EPS $1.95-2.25 vs ~$2.03 consensus.
- Bought back $99.3M of stock in Q3 ($173.5M year to date). Dividend $0.13.
- CEO Greg Smith: demand "extended across the AI value chain, from memory and hard disk drive test to high-speed interconnect and robotics."
- Reasons given in coverage for the drop: the sequential step-down in the outlook, and the open question of whether the second-half lull in compute test shipments is customer timing or early softening in AI test demand (Tickeron). The stock was also up ~59.5% YTD going into the print.
- The 10/28 8:30 ET call commentary was not yet available in any source searched. Orders and bookings are not disclosed in the release.
Sector
- The group is bouncing today after the 10/22 equipment sell-off: SMH $562.78, up from the $532-536 test.
- (inference) Teradyne is the only test name that has reported. FORM, COHU and AEHR have not reported Q3 yet, so today's peer strength does not yet say anything about test demand in their September quarters.
Risks
- Growth plateau: four flat quarters ($1.28B, $1.33B, $1.31B, guide $1.30B). The YoY comparisons get harder from here, since Q4'25 was already $1,083M.
- Margin drift: gross margin 60.9%, then 59.8%, then 59.1%; GAAP op margin 36.9%, then 32.9%, then 30.8%.
- Compute test timing: the 2H compute-test lull is unresolved. 2027 recovery is management's framing, not yet in numbers (inference).
- Pattern: three earnings sell-offs this year, including a full fade of a +14.7% gap in July. Post-report rallies have not held.
- Floor test: this is the 4th test of the ~$297-302 zone this year, and today traded under it. A daily close below it leaves no nearby 2026 support.
- Valuation: ~34x trailing GAAP EPS ($8.71) and P/S 9.3, with growth heading toward ~+20%.
Judgement
Justified. The business is not broken. Q3 beat and Q4 EPS guidance is above consensus; robotics turned profitable and memory test set a record. Nothing in the release confirms the Lam-style supply problem behind the 10/22 drop. But revenue has stopped growing quarter to quarter, YoY growth is heading from +104% to about +20%, and margins are slipping. A ~7-8% repricing on that, while peers rise, fits the facts. This is not an overreaction to a good report. Whether the long-standing ~$297-302 floor holds is a price question, not a business question.
Sources
- https://www.sec.gov/Archives/edgar/data/0000097210/000119312526434981/ter-ex99_1.htm
- https://www.investing.com/news/earnings/teradyne-falls-6-despite-strongerthanexpected-q3-print-guidance-93CH-4977003
- https://tickeron.com/blogs/teradyne-ter-delivers-strong-q3-beat-on-ai-demand-shares-fall-6-7-on-guidance-22475/
- https://investing.com/news/stock-market-news/afterhours-movers-stx-enph-hood-v-csgp-boom-cake-ppg-oi-ter-432SI-4976906
- https://www.chartmill.com/news/TER/Chartmill-56966-Teradyne-NASDAQTER-Falls-After-Hours-Despite-Q3-Beat-as-AI-Expectations-Remain-High
- https://www.marketbeat.com/instant-alerts/upcoming-teradyne-ter-set-to-post-earnings-on-tuesday-2026-10-20/
- https://www.fool.com/investing/2026/04/29/why-teradyne-tumbled-today/
- https://tikr.com/blog/teradyne-falls-19-after-record-q1-2026-earnings-was-that-a-buying-opportunity
- https://investors.teradyne.com/news-events/ir-calendar/detail/20261028-q3-2026-teradyne-inc-earnings-conference-call